Dyno Therapeutics is pioneering an artificial intelligence (AI) powered approach to gene therapy. Using machine learning and quantitative high-throughput in vivo experimentation, we are inventing new ways to design gene vectors with a focus on cell-targeting capsid proteins from adeno-associated virus (AAV), the most widely-used vector for gene therapies.

Software Engineering

Data Science

Cambridge, MA, USA

Dyno Therapeutics

KdT Ventures is a new age seed stage venture firm, with a focus on the intersection of technology and science.

Join Us